Thursday, September 17, 2026 | 10am EDT: Expand Bispecific Purification Strategies Beyond mAb Platforms

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

Northway Biotech Opens $70.8M Cell Therapy CDMO Facility in Vilnius, Lithuania
Vilnius, Lithuania, is home to Northway Biotech’s new cell therapy and personalized medicine manufacturing center.
News

From Oxfordshire to Wales: Where UK Life Sciences Investment Is Going in 2026
Cambridge is one of several UK life sciences hubs attracting new investment in R&D, manufacturing and biopharma infrastructure.
News

Bristol Myers Squibb Invests $2.3B in Houston Drug Manufacturing
Bristol Myers Squibb Houston manufacturing
News

Lilly and Resilience Invest $750M to Expand Medicine Production in Ohio
Lilly Resilience Ohio manufacturing investment
Pharmaville: Powering Life Sciences Location Strategy and FDI

Takeda to Invest Up to $30 Million in Indonesia Plasma Donation Pilot
Takeda Indonesia Plasma Pilot
Pharmaville: Powering Life Sciences Location Strategy and FDI

Related Webinars

October 30, 2026

The Expanding Peptide Conjugate Landscape: Strategies for Complex Peptide Synthesis
Hero - Desktop
October 21, 2026

Improve Clinical Trial Retention with Patient Population Support
Hero - Desktop
October 23, 2026

Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays
Hero - Desktop
October 30, 2026

Scale Cell & Gene Therapy Access for Stronger Launch (Broadcast 2)
Hero - Desktop
October 29, 2026

Scale Cell & Gene Therapy Access for Stronger Launch (Broadcast 1)
Hero - Desktop